Previous close | 24.32 |
Open | 24.58 |
Bid | 23.06 x 3000 |
Ask | 25.99 x 1100 |
Day's range | 24.53 - 24.85 |
52-week range | 16.63 - 26.16 |
Volume | |
Avg. volume | 5,264,593 |
Market cap | 16.791B |
Beta (5Y monthly) | 1.37 |
PE ratio (TTM) | 65.05 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the BofA Securities 2024 Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at approximately 10:00 a.m. Pacific Time.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2024.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2024 financial results before the market opens on Friday, April 26, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results.